| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $21.1B | $19.7B | $19.4B | $19.4B | $18.5B | $16.7B | $4.3B | $4.1B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $3.2B | $3.2B | $3.3B | $3.4B | $3.5B | $3.1B | $0.7B | $0.8B |
| Operating Income | $3.4B | $2.9B | $2.7B | $3.0B | $2.8B | $2.1B | $0.6B | $0.7B |
| Net Income | $2.2B | $2.2B | $2.1B | $2.3B | $2.1B | $1.4B | $0.4B | $0.6B |
| EPS (Basic) | $4.57 | $4.52 | $4.21 | $4.42 | $4.06 | $2.58 | $0.72 | $1.12 |
| EPS (Diluted) | $4.56 | $4.51 | $4.21 | $4.41 | $4.05 | $2.57 | $0.72 | $1.12 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $20.7B | $20.0B | $18.5B | $17.9B | $17.9B | $16.9B | $16.2B | $15.9B |
| Current Assets | $7.8B | $7.5B | $7.5B | $7.3B | $7.3B | $6.9B | $7.6B | $8.7B |
| Cash & Equivalents | $1.9B | $2.2B | $2.6B | $2.2B | $1.8B | $2.7B | $2.6B | $1.2B |
| Total Liabilities | $5.7B | $5.6B | $5.3B | $5.5B | $5.9B | $6.1B | $5.2B | $4.5B |
| Current Liabilities | $3.7B | $3.6B | $3.3B | $3.3B | $3.5B | $3.5B | $3.0B | $2.8B |
| Stockholders' Equity | $15.0B | $14.4B | $13.2B | $12.3B | $12.0B | $10.8B | $11.0B | $11.4B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $2.9B | $2.1B | $2.3B | $2.6B | $2.5B | $3.3B | $2.5B | $2.6B |
| Investing Cash Flow | $-0.2B | $-1.6B | $-0.3B | $-0.1B | $-2.2B | $-1.2B | $1.6B | $-1.6B |
| Capital Expenditures | $0.3B | $0.3B | $0.3B | $0.3B | $0.3B | $0.4B | $0.4B | $0.4B |
| Financing Cash Flow | $-2.3B | $-0.9B | $-1.6B | $-1.9B | $-1.2B | $-2.0B | $-2.6B | $-1.7B |